Based on their involvement in breast cancer and the availability of commercial antibodies, the ADIPOR1, ADORA1, BTG2 and CD46 genes were selected among the 27 previously identified genes to further investigate the association of protein expression levels to overall patient survival. The gene discussed is CD46; the disease is breast carcinoma.